Qingyun Tech Invited to Speak at the 7th Future Healthcare 100 Summit 2023 on Digital Pharma Marketing

“Only Ask for Courage, Only Ask for Blooming, No Questions of West or East” Makes a Powerful Arrival!

The 7th Future Healthcare Top 100 Conference, themed “Beyond East and West,” was hosted by VCBeat and Eggshell Research Institute, with strategic cooperation from Shanghai Zhangjiang Group. Integrating cutting-edge academic and research insights, comprehensive industry perspectives, and keen capital market trends, the conference was held at the Shanghai Zhangjiang Science Hall from May 5 to 7, 2023. It brought together industry peers to explore the innovative future of the broader health sector and embark on a new journey in healthcare innovation.

As one of the earliest innovative technology companies in China to deploy virtual representatives, Qingyun Technology offers a multi-channel digital marketing integrated solution. Leveraging comprehensive, multi-level insights into healthcare institutions and physicians, and empowered by artificial intelligence and deep machine learning, the solution precisely delivers high-value, highly relevant medical knowledge. Beyond providing precise academic content, Qingyun Technology’s virtual representatives deliver services to physicians at optimal times and within extremely granular scenarios. Through close interactions, the platform fosters sustained, positive communication between pharmaceutical enterprises and physicians. Physician feedback, in turn, serves as the source for continuous iteration of technology and services, enabling rapid response to the evolving pharmaceutical landscape and clinical needs, while building diverse engagement scenarios.

Implement a real-time, intelligent, and platform-based “ecosystem closed-loop” marketing solution. Moving forward, we will further accelerate the application upgrades and functional innovations of Qingyun Technology’s self-developed AI-driven digital marketing platform, while enhancing the omni-channel marketing network layout focused on county-level grassroots markets. By providing high-quality, efficient marketing data, tools, and services, we will comprehensively support pharmaceutical enterprises in advancing their digital marketing development and conversion.

Top 100 Future Healthcare ConferenceSpecialized Pharmaceutical Enterprise Digital Marketing Forum, Mr. Yan Guowei, founder of Qingyun Technology, will attend and deliver a presentation on"Hotspots and Trends in Digital Omnichannel Marketing"Keynote Address.

Conference Time:

May 5-7, 2023

Pharmaceutical Company Digital Marketing Forum Time:

May 6, 2023

Conference Venue:

Shanghai Zhangjiang Science Hall (No. 1393 Haike Road, Pudong New Area, Shanghai)

Conference Registration:

Qingyun Technology is China’s leading next-generation digital marketing technology platform, providing pharmaceutical companies with omnichannel intelligent marketing solutions centered on integrated online-to-offline (O2O) promotion.

Qingyun Technology leverages its self-developed SCRM system and algorithmic models to recommend personalized communication plans for physician outreach. Furthermore, Qingyun offers a diverse array of physician engagement channels—including field medical representatives, virtual representatives, and internet platforms—to deliver personalized medical services, thereby achieving the goal of precision marketing for pharmaceuticals and medical devices.

The company has amassed a network of over 600,000 primary care physicians. Since its establishment in 2017, it has provided highly effective novel digital marketing services to nearly 40 leading domestic and international pharmaceutical companies, including AstraZeneca, Pfizer, Merck, and Novartis. The therapeutic areas covered include cardiovascular diseases, diabetes, respiratory conditions, urology, oncology, and other disease fields. With an annual business growth rate exceeding 100%, the company has emerged as a leader in the new digital marketing sector. The Qingyun management team comprises senior executives from top Chinese CSO (Contract Sales Organization) enterprises and multinational pharmaceutical companies, and the current team size has reached 800 employees.